Stereotaxic instruments are medical devices that are used to precisely locate structures inside the brain and nervous system during minimally invasive procedures. They incorporate high-precision guidance systems along with patient imaging to enable surgeons to accurately position surgical accessories such as biopsy probes, catheter systems and electrodes within the brain and spinal cord. Such instruments have revolutionized the treatment of several neurological conditions. The Global Stereotaxic Instruments Market Size is estimated to be valued at US$ 165 million in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Technological advancements in image-guided surgery have been a major growth driver for the stereotaxic instruments market. Advanced imaging modalities such as MRI, CT scans and PET scans provide high quality 3D visualization of internal structures to guide surgical procedures. Sophisticated navigation systems integrated with patient imaging allow precise, real-time tracking of surgical tools during delicate interventions within the brain and spinal column. Adoption of robotics is also gaining ground, with robotic stereotaxic instruments offering advantages of greater precision, smaller incisions and reduced procedure time. Advanced localization capabilities combined with minimally invasive approaches have expanded the applications of stereotaxic surgery in treating several neurological disorders.
Segment Analysis
The global stereotaxic instruments market is dominated by the small animal stereotaxic instruments segment. Small animal stereotaxic instruments are widely used for neuroscience research that involves various procedures like brain imaging, electrophysiology, and microinjection being performed on rodents. These instruments help secure the animal's head in place to allow precise manipulation and access to the brain structure. Their demand is driven by increasing adoption of these surgical tools in drug development and discovery research activities employing animal models.
Key Takeaways
The global stereotaxic instruments market is expected to witness high growth over the forecast period of 2024 to 2031.
Regional analysis comprises: North America currently dominates the market and is expected to continue its lead over the forecast period. This can be attributed to extensive neuroscience research in the region along with the presence of major players. The strong focus on developing treatments for brain disorders, supported by government funding, further boosts the regional market.
Key players operating in the stereotaxic instruments market are Stoelting Co., UNO BV, Harvard Apparatus, David Kopf Instruments, Electronics & Innovation Ltd., World Precision Instruments (WPI), KOPF INSTRUMENTS, RWD Life Science Co. Ltd., Bioseb, and Neurostar. They maintain their standing in the market through extensive R&D efforts and new product launches catering to evolving research needs. For instance, in 2021, RWD Life Science launched a new stereotaxic instrument - UltraPrecise Small Animal Stereotaxic with capabilities like enhanced positioning accuracy and higher level of precision.
Get More Insights Here: https://www.newswirestats.com/stereotaxic-instruments-market-demand-growth-and-regional-outlook-by-2030/
